Generate Biomedicines, Inc. (GENB) vs Nurix Therapeutics, Inc. (NRIX)
- Generate Biomedicines, Inc. GENB 13.06 +3.90%
- Nurix Therapeutics, Inc. NRIX 15.30 +3.10%
Generate Biomedicines, Inc. and Nurix Therapeutics, Inc. are both Biotechnology companies. Generate Biomedicines, Inc. and Nurix Therapeutics, Inc. are of similar size ($1.6B and $1.6B). Generate Biomedicines, Inc. has negative trailing earnings, so its P/E is not meaningful; Nurix Therapeutics, Inc. trades at 6.1×. Nurix Therapeutics, Inc. has the higher net margin (42.0% vs −781.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Nurix Therapeutics, Inc. leads on 13 and Generate Biomedicines, Inc. on 1.
Valuation
Profitability
| Metric | GENB | NRIX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 68.51% |
| Operating margin | (751.19%) | 41.27% | 0.00% |
| Net margin | (781.10%) | 42.01% | 0.00% |
| Free cash flow margin | (1,692.17%) | 52.68% | 0.00% |
| Return on equity | 0.00% | 43.99% | (51.96%) |
| Return on assets | (90.35%) | 34.33% | (46.06%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack